Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

ClinicalTrials.gov ID: NCT05818085

Public ClinicalTrials.gov record NCT05818085. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 10:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-blind, Controlled, Phase 2b/3 Study to Assess the Efficacy and Safety of ABP-671 in Participants With Gout

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare the efficacy and safety of different doses and regimens of ABP-671 with placebo and allopurinol. Part 2 of the study will compare the dosing regimen(s) of ABP-671 selected from Part 1 with placebo in participants who have not been enrolled for Part 1.

Study identification

NCT ID
NCT05818085
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Atom Therapeutics Co., Ltd
Industry
Enrollment
300 participants

Conditions and interventions

Conditions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
19 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 10, 2023
Primary completion
Jan 29, 2025
Completion
Mar 29, 2025
Last update posted
Dec 21, 2025

2023 – 2025

United States locations

U.S. sites
35
U.S. states
17
U.S. cities
30
Facility City State ZIP Site status
Alliance for Multispecialty Research Tempe Arizona 85281
Tucson Neuroscience Research, LLC Tuscon Arizona 85710
Anaheim Clinical Trials (Cenexel ACT) Anaheim California 92801
Center for Clinical Trials of Sacramento Sacramento California 95823
Access Research Institute Brooksville Florida 34613
Nature Coast Clinical Reasearch Crystal River Florida 34429
JY Research Institute Inc. Cutler Bay Florida 33189
Accel Clinical Research Site DeLand Florida 32720
Jacksonville Center for Clinical Research Jacksonville Florida 32216
Accel Research Sites Network - St. Pete-Largo Clinical Research Unit Largo Florida 33777
A & D Doctor Center Miami Florida 33135
Bioclinical Research Alliance Miami Florida 33155
Cordova Research Institute Miami Florida 33155
Century Research LLC Miami Florida 33173
ITB Research Miami Florida 33173
Combined Research Orlando Phase I-IV Orlando Florida 32807
New Horizons Research Palmetto Bay Florida 33158
Advanced Clinical Research of Atlanta Atlanta Georgia 30309
Centricity Research Columbus Georgia 31904
Alliance for Multispecialty Research, LLC. Newton Kansas 67114
DelRicht Research New Orleans Louisiana 70115
AMR New Orleans Louisiana 70119
Annapolis Internal Medicine/CCT Research Annapolis Maryland 21401
DelRicht Research of Gulfport Gulfport Mississippi 39501
Quality Clinical Research, Inc Omaha Nebraska 68114
Santa Rosa Medical Center Las Vegas Nevada 89119
Inspire Santa Fe Medical Group Santa Fe New Mexico 87505
OnSite Clinical Solutions Salisbury North Carolina 28144
DelRicht Research Tulsa Oklahoma 74133
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
ClinSearch Chattanooga Tennessee 37421
Medical Care/CCT Elizabethton Tennessee 37643
PanAmerican Clinical Research, LLC Brownsville Texas 78520
Quality Research Inc. San Antonio Texas 78209
Centricity Research Suffolk Virginia 23435

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05818085, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 21, 2025 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05818085 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →